UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Veracyte, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

20-5455398

(State of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

7000 Shoreline Court, Suite 250
South San Francisco, California

 

94080

(Address of principal executive offices)

 

(Zip Code)

 

Securities to be Registered Pursuant to Section 12(b) of the Act

 

Title of each class
to be so registered

 

Name of each exchange on which
each class is to be registered

Common Stock, $0.001 par value per share

 

The NASDAQ Stock Market LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o

 

Securities Act registration statement file number to which this form relates:  333-191282

 

Securities to be registered pursuant to Section 12(g) of the Act:

 

Not applicable

(Title of class)

 

 

 



 

Item 1.                                                         Description of Registrant’s Securities to be Registered.

 

A description of the common stock, par value $0.001 per share (the “Common Stock”), of Veracyte, Inc., a Delaware corporation (the “Registrant”), to be registered hereunder is contained in the section entitled “Description of Capital Stock” in the prospectus included in the Registrant’s Registration Statement on Form S-1 (File No. 333-191282), initially filed with the Securities and Exchange Commission on September 20, 2013, as amended from time to time (the “Registration Statement”), and is incorporated herein by reference. In addition, a description of the Common Stock will be included in a prospectus to be subsequently filed by the Registrant pursuant to Rule 424(b) of the Securities Act of 1933, as amended, relating to the Registration Statement, and such prospectus is incorporated herein by reference.

 

The Common Stock has been approved for listing on the NASDAQ Global Market of The NASDAQ Stock Market LLC under the symbol “VCYT.”

 

Item 2.                                                         Exhibits.

 

Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC, and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

2



 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

Veracyte, Inc.

 

 

 

 

Dated: October 28, 2013

By

/s/ Bonnie H. Anderson

 

 

Bonnie H. Anderson

 

 

President and Chief Executive Officer

 

3